Rediff.com« Back to articlePrint this article

Index heavyweights lift Sensex, Nifty to lifetime highs

Last updated on: June 11, 2021 19:57 IST

Dr Reddy's was the top gainer in the Sensex pack, rising over 3 per cent, followed by PowerGrid, TCS, HCL Tech, Infosys and Reliance Industries.

On the other hand, L&T, IndusInd Bank, Bajaj Finserv and Bharti Airtel were among the laggards.

Broker

Photograph: Utpal Sarkar/ANI Photo

Equity benchmarks darted up to fresh lifetime highs on Friday as IT, pharma and energy counters saw brisk buying in tandem with a bullish trend overseas.

After touching a record intra-day peak of 52,641.53, the 30-share BSE Sensex ended 174.29 points or 0.33 per cent up at its new closing high of 52,474.76.

 

Similarly, the broader NSE Nifty advanced 61.60 points or 0.39 per cent to its lifetime peak of 15,799.35.

Dr Reddy's was the top gainer in the Sensex pack, spurting 3.03 per cent, followed by PowerGrid, TCS, Infosys, HCL Tech, Reliance Industries and Tech Mahindra.

On the other hand, L&T, IndusInd Bank, Bajaj Finserv, Bharti Airtel, ICICI Bank, Axis Bank and ITC were among the laggards, dropping up to 1.07 per cent.

During the week, the Sensex jumped 374.71 points or 0.71 per cent, while the Nifty advanced 129.10 points or 0.82 per cent.

"Tracking cues from positive global markets, Indian equities remained in the green zone in today's session. US CPI data, released on Thursday, eased inflation worries as the current surge is temporary and insufficient for the Fed to taper its bond-buying policy.

Sensex trend 2021

* January 21: Touches the momentous 50,000-mark in intra-day trade on January 21, 2021

* February 3: Closes above 50,000 for the first time

* February 5: Crosses 51,000-mark in intra-day trade

* February 8: Ends above 51,000-level

* February 15: Rallies above 52,000-mark

* May 24: Market capitalisation of all BSE-listed companies touches USD 3 trillion

* June 11: Reaches lifetime intra-day high of 52,641.53 points; closes at all-time high of 52,474.76; market capitalisation of all BSE-listed companies at record Rs 2,31,11,214.71 crore

* Has gained 4,723.43 points or 9.89 per cent so far this year.

"Global sentiments were further boosted with European Central Bank raising its growth estimates and pledging its liquidity support," said Vinod Nair, Head of Research at Geojit Financial Services.

Paras Bothra, president of Equity Research at Ashika Group, said domestic markets remained firm on expectations of improving consumer and business confidence amid phased easing of lockdowns and declining new COVID-19 cases.

"The government also does not expect the economic impact of the second wave of the COVID-19 pandemic to be as severe as the first," he added.

Sector-wise, BSE metal, IT, energy, teck, basic materials and healthcare indices rallied up to 3.21 per cent, while realty, capital goods, bankex, telecom, consumer durables and FMCG nursed losses.

Broader BSE midcap and smallcap indices rose up to 0.40 per cent.

World markets remained on a firm footing after the S&P 500 surged to a record high despite a spike in consumer prices in the US. Dovish comments from ECB also buoyed investor sentiment.

Elsewhere in Asia, bourses in Shanghai and Tokyo were in the red, while Hong Kong and Seoul ended on a positive note.

The rupee slipped 1 paisa to end at 73.07 against the US dollar amid strengthening of the American currency against key rivals and rising crude oil prices.

Foreign institutional investors (FIIs) remained net buyers in the capital markets, as they purchased shares worth Rs 1,329.70 crore on Thursday, as per provisional data.

The daily COVID-19 count in India remained below the one-lakh mark for the fourth consecutive day with the country reporting 91,702 fresh cases, while the daily  positivity rate dropped to 4.49 per cent, according to the Union Health Ministry data updated on Friday.

© Copyright 2024 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.